• Financial Results

Morepen Labs’ Net Profit Rises by 153 Per cent Led by Strong API Business in Q1’FY 2020-21

New Delhi, August 31, 2020: Highlights: Q1’fy 2020-21 (Consolidated) Performance at a Glance (Rs. in Crores) Particulars Q1’FY 2020-21 Q1’FY 2019-20…

• Awareness

Morepen Labs takes up the Covid battle with its Infrared Thermometers, Hand Sanitizers and Face Masks in Indian market

Company gets license to manufacture Hydroxychloroquine (HCQ) New Delhi, April 20, 2020: Morepen Laboratories Ltd. is all set to be…

• Financial Results

Morepen Labs’ net profit rises by 21% in Q3 FY 2019-20 led by a stable performance in all business segments

Highlights of Q3 FY 2019-20 (Consolidated): The Net Profit after Tax during the period stood at Rs. 10.81 crore, up…

• Market

Morepen Labs Catches Pharma Sector Uptrend in Q1 FY 2019-20. Company’s Net Profit Rises by a Whopping 256 Percent Led by a Significant Jump in its APIs Exports

New Delhi, Delhi, India Highlights Q1 FY 2019-20 (Standalone): Net Sales Revenue recorded a pure organic growth of 25.4 per…

Morepen Labs begins FY 2018-19 with a Sound Performance in the First Quarter

Company reports 93 percent rise in its consolidated net profit and 26 percent rise in its consolidated net sales revenue…

Twin USFDA Approvals for Morepen Labs’ Bulk Drugs (API) Facilities

Baddi facility gets US FDA nod for bulk drug “Atorvastatin” and Masulkhana facility for “Montelukast” New Delhi, August 05, 2018:…

Morepen Labs Reports Growth-filled Fourth Quarter to Close FY 2017-18 with a 25 Per cent Rise in its Net Profit

New Delhi, May 18, 2018: Highlights 12M FY 2017-18 (Consolidated) Net profit rises by 25 per cent at Rs. 29.59 Crore.…